February 2012 Drug Update Information - Pharmacy Benefits ...

More documents

Recommendations

Info

Cilostazol tablets, Apotex 50 mg, 60 count (NDC 60505-2521-01) 100 mg, 60 count (NDC 60505-2522-01) Cilostazol tablets, Teva 100 mg, 100 count, unit dose (NDC 00172-5841-10) Reason for the Shortage Sandoz had cilostazol in short supply due to a shortage of raw materials. Apotex and Teva cannot provide a reason for the shortage. Mylan discontinued cilostazol tablets in August, 2011. Article Link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=809 Source: http://www.a ashp.org Clarithromycin Immediate-Release Tablets January 27, 2012 Products Affected - Description Clarithromycin immediate-release tablets, Apotex 250 mg, 60 count (NDC 60505-2616-06) 500 mg, 60 count (NDC 60505-2615-06) Clarithromycin immediate-release tablets, Mylan 250 mg, 60 count (NDC 00378-8250-91) 500 mg, 60 count 9NDC 00378-8500-91) Clarithromycin immediate-release tablets, Ranbaxy 250 mg, 60 count (NDC 63304-0725-60) 250 mg, 100 count (NDC 63304-0725-01) 500 mg, 60 count (NDC 63304-0726-60) 500 mg, 100 count (NDC 63304-0726-01) Clarithromycin immediate-release tablets, Sandoz 250 mg, 60 count (NDC 00781-1961-60) 500 mg, 60 count (NDC 00781-1962-60) Biaxin immediate-release tablets, Abbott 250 mg, 100 count unit dose (NDC 00074-3368-11) - discontinued 250 mg, 60 count (NDC 00074-3368-60) 500 mg, 100 count, unit dose (NDC 00074-2586-11) Reason for the Shortage Ranbaxy has an import ban on their products. Apotex import ban has been lifted, but the company has not resumed production of clarithromycin immediate-releasee tablets. Abbott, Mylan, and Sandoz and cannot provide a reason for the shortage. Article Link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=726 Source: http://www.a ashp.org Echothiophate Powder for Ophthalmic Solution January 27, 2012 Products Affected - Description Phospholine Iodide 0.125%, Pfizer 5 mL bottle (NDC 00046-1065-05) Reason for the Shortage Pfizer (formerly Wyeth) states Phospholine Iodide is in short supply due to a raw material shortage. Article Link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=85 34
Source: http://www.a ashp.org Haloperidol Decanoate Injection January 27, 2012 Products Affected - Description Haloperidol decanoate injection, Bedford 50 mg/mL, 1 mL vials (NDC 55390-0412-01) - discontinued 50 mg/mL, 5 mL vials (NDC 55390-0412-05) - discontinued 100 mg/mL, 1 mL vial (NDC 55390-0413-01) - discontinued 100 mg/mL, 5 mL vial (NDC 55390-0413-05) - discontinued Haloperidol decanoate injection, Teva 50 mg/mL, 1 mL vial (NDC 00703-7011-03) 50 mg/mL, 5 mL vial (NDC 00703-7013-01) 100 mg/mL, 1 mL vial (NDC 00703-7021-03) 100 mg/mL, 5 mL vial (NDC 00703-7023-01) Haloperidol decanoate injection, Apotex 50 mg/mL, 5 mL vial (NDC 60505-0702-01) - discontinued 50 mg/mL, 5 mL Novaplus vial (NDC 60505-6020-02) - discontinued 100 mg/mL, 5 mL vial (NDC 60505-0703-01) - discontinued 100 mg/mL, 5 mL Novaplus vial (NDC 60505-6021-02) - discontinued Haldol decanoate injection, Ortho-McNeil 50 mg/mL, 1 mL ampule, 10 count (NDC 00045-0253-01) - discontinued 50 mg/mL, 1 mL ampule (NDC 00045-0253 -03) – NDC number discontinued 100 mg/mL 1 mL ampule (NDC 00045-0254-14) – NDC number discontinued Reason for the Shortage Teva products are on shortage due to manufacturing delays. Bedford discontinuedd haloperidol decanoate in May, 2011 to concentrate on the manufacturing of other products. Apotex has discontinued all haloperidol decanoate presentations. Ortho-McNeil discontinued the 50 mg/mL 1 mL ampule 10 count presentations in late-June, 2010. Article Link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=526 Source: http://www.a ashp.org Haloperidol Lactate Injection January 27, 2012 Products Affected - Description Haloperidol lactate 5 mg/mL injection, Bedford 1 mL vial (NDC 55390-0147-10) 10 mL vial (NDC 55390-0147-01) Novaplus 1 mL vial (NDC 55390-0447-10) - discontinued Haloperidol lactate 5 mg/mL injection, Pfizer 1 mL vial (NDC 00069-0113-02) Haloperidol lactate 5 mg/mL injection, Teva 1 mL vial (NDC 00703-7041-03) 10 mL vial (NDC 00703-7045-01) Haloperidol lactate 5 mg/mL injection, Ortho-McNeil 1 mL ampules (NDC 00045-0255-01) - NDC number discontinued Reason for the Shortage APP and Pfizer have haloperidoll lactate on shortage due to increased demand. 35
Page 1 and 2: February 2012 Drug Information Upda
Page 3 and 4: GENERIC DRUG NAME GENERIC APPROVAL
Page 5 and 6: CICLOPIROX/ TOPICAL PEDIPIROX-4 New
Page 7 and 8: [Posted 01/09/2012] ISSUE: Novartis
Page 9 and 10: Studies Article Link: http://www.fd
Page 11 and 12: the use of XARELTO® (rivaroxaban),
Page 13 and 14: acteria. The Food and Drug Administ
Page 15 and 16: Statins raise risk of Type 2 diabet
Page 17 and 18: The Million Women Study, a U.K. pro
Page 19 and 20: Azithromycin 250 mg tablets, 1 card
Page 21 and 22: RECALLING FIRM/MANUFACTURE Recallin
Page 23 and 24: Recalling Firm: Pfizer Us Pharmaceu
Page 25 and 26: 250 mg, 100 count (NDC 00591-3969-0
Page 27 and 28: Sandoz states the shortage is due t
Page 29 and 30: 5 mL ampule (NDC 10019-0033-72) 20
Page 31 and 32: Article Link: http://www.ashp.org/D
Page 33: Lidocaine 2% (with epinephrine 1:10
Page 37 and 38: ecome unavailable for an extended t
Page 39 and 40: American Regent resumed manufacturi
Page 41 and 42: Trandate tablets, Prometheus 100 mg
Page 43 and 44: Article link: http://www.ashp.org/D
Page 45 and 46: Bedford Laboratories has multiple p
Page 47 and 48: Thiothixene capsules, Mylan 2 mg ca
Page 49 and 50: 20 mL vials (NDC 10019-0905-03) - d
Page 51 and 52: 500 mg extended release, 500 count
Page 53 and 54: 1 mg/mL, 4 mL vial (NDC 25021-0781-
Page 55 and 56: West-Ward states the shortage is du
Page 57 and 58: 150 mL bottle (NDC 63304-0954-02) C

February 2012 Drug Update Information - Pharmacy Benefits ...

Create successful ePaper yourself

Delete template?

Save as template?